VANGUARD GROUP INC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 188 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$360,237,925
-57.9%
9,469,977
+0.7%
0.01%
-55.0%
Q2 2023$856,457,519
+36.3%
9,401,290
-1.3%
0.02%
+25.0%
Q1 2023$628,529,146
+31.9%
9,528,944
+3.4%
0.02%
+23.1%
Q4 2022$476,377,910
-22.8%
9,212,491
+2.0%
0.01%
-27.8%
Q3 2022$616,823,000
+56.3%
9,031,079
+3.5%
0.02%
+63.6%
Q2 2022$394,623,000
-9.4%
8,726,745
+1.8%
0.01%
+10.0%
Q1 2022$435,400,000
+16.3%
8,569,170
+8.2%
0.01%
+25.0%
Q4 2021$374,320,000
+68.2%
7,917,099
+17.3%
0.01%
+33.3%
Q3 2021$222,555,000
-44.5%
6,752,285
+6.4%
0.01%
-40.0%
Q2 2021$400,969,000
+53.1%
6,344,456
+3.9%
0.01%
+42.9%
Q1 2021$261,945,000
-17.4%
6,104,517
+10.2%
0.01%
-22.2%
Q4 2020$316,992,000
+143.3%
5,541,825
+28.3%
0.01%
+125.0%
Q3 2020$130,285,000
-9.1%
4,318,357
-1.6%
0.00%
-20.0%
Q2 2020$143,318,000
+76.4%
4,388,181
+44.7%
0.01%
+66.7%
Q1 2020$81,267,000
+9.9%
3,033,471
+25.6%
0.00%0.0%
Q4 2019$73,926,000
+42.3%
2,414,314
+11.9%
0.00%
+50.0%
Q3 2019$51,965,000
-0.0%
2,157,086
+5.2%
0.00%0.0%
Q2 2019$51,968,000
+33.0%
2,050,838
+2.4%
0.00%0.0%
Q1 2019$39,064,000
+105.7%
2,003,283
+39.1%
0.00%
+100.0%
Q4 2018$18,994,000
-24.5%
1,440,038
+1.8%
0.00%0.0%
Q3 2018$25,157,000
-14.8%
1,414,900
+5.4%
0.00%0.0%
Q2 2018$29,530,000
+249.0%
1,342,290
+250.8%
0.00%
Q1 2018$8,461,000
+42.3%
382,653
+39.6%
0.00%
Q4 2017$5,947,000274,0740.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 2,503,059$170,959,00029.50%
ACUTA CAPITAL PARTNERS, LLC 554,000$37,838,00016.29%
Avoro Capital Advisors LLC 10,125,000$691,538,00012.78%
Sio Capital Management, LLC 507,700$34,676,00011.02%
Logos Global Management LP 1,300,000$88,790,00010.92%
EcoR1 Capital, LLC 5,183,431$354,028,00010.45%
Cormorant Asset Management, LP 1,478,000$100,947,0007.06%
Finepoint Capital LP 266,090$18,174,0005.98%
Ghost Tree Capital, LLC 275,000$18,783,0005.27%
Boxer Capital, LLC 1,303,700$89,043,0005.01%
View complete list of APELLIS PHARMACEUTICALS INC shareholders